Notebook

Getting Leaner But Not Meaner All You Need is Drugs Thanks, But The Answer's No Spreading The News Researchers have an obligation to think about what's good for society as well as what's important for science, says Rep. George Brown (D-Calif.), chairman of the House Science, Space, and Transportation Committee. Such public-spirited thinking, he says, could lead to a smaller federal research budget but a healthier citizenry and stronger national economy. Speaking at the National Academy of Sc

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Getting Leaner But Not Meaner All You Need is Drugs Thanks, But The Answer's No Spreading The News Researchers have an obligation to think about what's good for society as well as what's important for science, says Rep. George Brown (D-Calif.), chairman of the House Science, Space, and Transportation Committee. Such public-spirited thinking, he says, could lead to a smaller federal research budget but a healthier citizenry and stronger national economy. Speaking at the National Academy of Sciences to a group gathered to discuss a new report that argues for the need to set priorities in space research, Brown warned his audience that "we must stop choosing between science and social assistance, and start asking how we can be responsible about both. This may mean leaner science budgets that more effectively accomplish good science." Brown also said he "could envision a vital space science program without a space station, or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies